Founded by Dr. Lucy Gilbert, the McGill University Health Centre’s (MUHC) Detecting Ovarian and Endometrial Cancer Early (DOvEE) project is the only one of its kind in the world. A longtime supporter of DOvEE, the MUHC Foundation announced Wednesday that it is launching a campaign to raise $2 million for the cause.
Dr. Gilbert and her team of clinicians and researchers are working to stop ovarian and endometrial cancers by increasing awareness of symptoms through satellite testing clinics around Montreal and offering free fast-tracked diagnostic testing to symptomatic women without a doctor’s referral.
Montreal supports DOvEE
The DOvEE team is pushing for the early screening of ovarian and endometrial cancers by developing a test that provides a safe and minimally invasive method to detect ovarian and endometrial cancers at an earlier stage than currently possible with existing tests. This will transform lives, as it has the potential to increase survival rates.
“There has been no improvement in the cure rate of ovarian cancer in 30 years and this is unacceptable,” says Dr. Gilbert. “If you look at a cell phone or computer from 30 years ago, today’s versions are tremendously different, and these types of advancements need to happen with respect to the early diagnosis of ovarian cancer.”
All women deserve to beat the silent killer
This year alone, 7,300 and 2,800 Canadian women will be diagnosed with endometrial and ovarian cancers respectively. Together, they are the third leading causes of cancer-related death in North American women. Ovarian cancer in particular is often called the silent killer because it can mimic other ailments until it is far too late. Although early detection holds the key to improving survival rates for ovarian and endometrial cancers, there are currently no reliable screening tests to diagnose these two deadly types of cancers at their earliest possible stage.